Prostate Clinical Trials Search

Current State: NCT ID:
Return to Map
TitleStateStatusNCT ID
Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone MetastasesOhioRecruitingNCT00079001
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate CancerOhioRecruitingNCT00309985
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain MetastasesOhioRecruitingNCT00377156
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate CancerOhioRecruitingNCT00430183
Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation TherapyOhioRecruitingNCT00450411
Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate CancerOhioRecruitingNCT00551525
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising PSA After Surgery for Prostate CancerOhioRecruitingNCT00567580
A Multicenter Clinical Study of the Sonablate®500 for the Treatment of Locally Recurrent Prostate Cancer With HIFUOhioRecruitingNCT00772317
Salvage Cryotherapy in Recurrent Prostate CancerOhioRecruitingNCT00824928
Study of Immunotherapy to Treat Advanced Prostate CancerOhioRecruitingNCT00861614
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone MetastasesOhioRecruitingNCT00874211
F18PET/CT Versus TC-MDP Scanning to Detect Bone MetsOhioRecruitingNCT00882609
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerOhioRecruitingNCT00936390
Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract CancerOhioRecruitingNCT00942331
Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing ProstatectomyOhioRecruitingNCT01009736
A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and NeckOhioRecruitingNCT01059643
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate CancerOhioRecruitingNCT01120236
Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate CancerOhioRecruitingNCT01188187
Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate CancerOhioRecruitingNCT01193257
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)OhioRecruitingNCT01194960
Study of Abiraterone Acetate in Patients With Advanced Prostate CancerOhioAvailableNCT01217697
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate CancerOhioRecruitingNCT01234311
Diet in Altering Disease Progression in Patients With Prostate Cancer on Active SurveillanceOhioRecruitingNCT01238172
Bicalutamide With or Without MK2206 in Treating Patients With Previously Treated Prostate CancerOhioRecruitingNCT01251861
A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate CancerOhioRecruitingNCT01288911
A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.OhioRecruitingNCT01302054
A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of FesoterodineOhioRecruitingNCT01302067
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerOhioRecruitingNCT01306890
Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate CancerOhioRecruitingNCT01308567
Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate CancerOhioRecruitingNCT01308580
Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone TherapyOhioRecruitingNCT01309672
A Phase 3 Efficacy Study of a Recombinant Vaccinia Virus Vaccine to Treat Metastatic Prostate CancerOhioRecruitingNCT01322490
Effectiveness of Open and Robotic ProstatectomyOhioRecruitingNCT01325506
EMD525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate CancerOhioRecruitingNCT01360840
Improving Continence and Quality of Life in Prostate Cancer PatientsOhioRecruitingNCT01365182
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerOhioRecruitingNCT01368588
A Study to Assess Efficacy and Safety With VESIcare® to Improve Urinary Continence in Subjects After Robotic Assisted Radical ProstatectomyOhioRecruitingNCT01371994
Tivantinib in Treating Patients With Metastatic Prostate CancerOhioRecruitingNCT01519414
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate CancerOhioRecruitingNCT01522443
PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder TumorsOhioNot yet recruitingNCT01567462
Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate CancerOhioRecruitingNCT00063882